Santa Barbara Dermatology Meeting 2024 - May 2 – May 5, 2024

Each year, nationally recognized leaders in medical, procedural, and aesthetic medicine convene in Santa Barbara to discuss and review the current state of knowledge in their respective dermatologic specialties. This program in medical dermatology features key clinical topics, including atopic dermatitis, acne vulgaris, cutaneous cancers, rosacea, psoriasis, and other important issues. Aesthetic medicine continues to be a growing specialty in the milieu of the aging American population and medical consumers’ ever-increasing desire to achieve the best possible quality of life at any age.
When May 02, 2024 08:30 AM to
May 05, 2024 12:00 PM
Where Ojai Valley Inn, 905 Country Club Road, Ojai, CA 93023
Contact Name
Contact Phone 615-579-8798
Add event to calendarvCal


Target Audience

Dermatologists, Nurse Practitioners, Physician Assistants, and Registered Nurses.

Click on the Session Title or Presenters Name to View the Course Presentation, then Click the Back Arrow to Return to This Page. The presentations are password protected. Please contact  to receive the password.

FRIDAY May 3, 2024
8:30-9:00 am    
Lecture: Photodynamic Therapy on Steroids
Melanie Palm, MD

9:00-9:30 am    
Lecture: How I Approach Psoriatic Arthritis
Ken Gordon, MD

9:30-10:00 am    
Lecture: New Treatments for Connective Tissue Diseases
David Fiorentino, MD

10:00-10:20 am

10:20-10:50 am
Lecture: Update on Billing and Coding
Alexander Miller, MD

10:50-11:20 am
Panel Q&A
Morning Panel: Melanie Palm, MD; Kenneth Gordon, MD; David Fiorentino, MD; Alexander Miller, MD

11:20-12:00 pm
Lecture: How to Get Better Closures
Roberta Sengelmann, MD; Alexander Miller, MD

12:00-1:30 pm

1:30-2:00 pm
Resident Symposium
Racial, Ethnic, and Gender Disparities in Cutaneous T-cell Lymphoma
Nicole Bolick, MD, MPH
Autochthonous Leprosy in Missouri
Andrea Gilmore, MD
2:00-2:30 pm
Lecture: How an Oncologist Treats Melanoma
Julian Davis, MD

3:30-5:00 pm
Lecture: Dermatopathology Great Cases
Johanna Moore, MD; Aegean Chan, MD; Ryan “Dutch”Berry, MD; Ursula Lang, MD; Pyam Abrishami, MD, Ryanne Brown, MD

SATURDAY May 4, 2024         
8:30-9:00 am
Treatment Options for Melasma
Kavita Mariwalla, MD

9:00-9:30 am
Lecture: What’s New in Pediatric Dermatology
Lawrence Eichenfield, MD

9:30-10:00 am
Lecture: JAK Inhibitors: The Good, the Bad and the Reality
Jennifer Soung; MD

10:00 10:20 am

10:20-10:50 am
Keynote Lecture: Navigating the Therapeutic Zoo in Psoriasis
Kenneth Gordon, MD

10:50-11:20 am
Panel Q&A    

Morning Panel: Kenneth Gordon, MD; Lawrence Eichenfield, MD; Jennifer Soung, MD; Julian Davis. MD

11:20-12:00 pm
Lecture: Therapeutics Master Panel
Michael Heffernan, MD; Kenneth Gordon, MD; Jennifer Soung, MD; David Fiorentino, MD; Lawrence Eichenfield, MD

12:00-1:30 pm
1:30-2:00 pm
Lecture: Approach to Nonscarring Alopecia and New Treatment Options
Jennifer Soung, MD

2:00-4:15 pm
Lecture: Live Patient Demonstration

Roberta Sengelmann, MD; Kavita Mariwalla, MD; Melanie Palm, MD

SUNDAY May 5, 2024        
8:30-9:00 am
Lecture: Two Truths and a Lie About Cosmetic Ingredients
Kavita Mariwalla, MD

9:00-9:30 am
Lecture: Update on Atopic Dermatitis
Lawrence Eichenfield, MD

9:30-10:00 am
Lecture: Update on Dermatomyositis
David Fiorentino, MD

10:00-10:30 am
Lecture: Tips for Neck Restoration with Fillers
Melanie Palm, MD

10:30-11:00 am
Lecture: How an Oncologist Treats NMSC
Julian Davis, MD

11:00-11:20 am
Panel Q&A
Morning Panel: Kavita Mariwalla, MD; David Fiorentino, Davis, MD; Julian Davis, MD; Melanie Palm, MD; Lawrence Eichenfield, MD

11:20-12:00 pm
Lecture: Grand Rounds
Michael Heffernan, MD; David Fiorentino, MD; Lawrence Eichenfield, MD

12:00 pm
Adjourn/Box Lunch

Course Directors
 Michael Heffernan, MD
US Dermatology Director for Probity Medical Research
San Luis Dermatology & Heffernan Consulting
San Luis Obispo, CA
Dr. Heffernan is an internationally recognized complex medical dermatologist and clinical trialist. After serving as the  founding chair of Dermatology at the Wright State University Boonshoft School of Medicine he served as a Distinguished  Medical Fellow for Eli Lilly & Co. He is now the co-owner of San Luis Dermatology & Laser Clinic and he is the US  Dermatology Lead for Probity Medical Research. Dr. Heffernan has published over 80 peer reviewed articles and  textbook chapters. He has been the principle investigator for nearly 150 research studies and he has provided over 500  invited lectures around the globe.

 Roberta D. Sengelmann, MD
Aesthetics/Dermatologic Surgery Director
Associate Clinical Professor at UC Irvine
Department of Dermatology
Director, Santa Barbara Skin Institute
Santa Barbara, CA
Roberta is Founder and Owner of the Santa Barbara Skin Institute where she is in full time practice. Raised in California, she returned in 2008 after a decade as Director of Dermatologic Surgery/ Mohs Fellowship Training at Washington University School of Medicine. She currently serves as an Associate Clinical Professor at UC Irvine Department of Dermatology. Her private practice focuses on Mohs/Skin Cancer & Reconstructive Surgery, as well as Aesthetic Laser & Minimally-Invasive techniques. She is active in her specialty's key organizations and has served on the Board of Directors of the American College of Mohs Surgery, the American Society for Dermatologic Surgery, and the International Transplant Skin Cancer Collaborative. She is Co-Founder and previous Chair of the WDS’ Women’s Dermatologic Surgery Committee. She has authored over 50 manuscripts, edited the first edition of the textbook 'Surgery of the Skin', and has given countless talks nationally and internationally mostly related to Mohs reconstruction and Facial Rejuvenation. Dr. Sengelmann is best known for her elegant surgical technique and attention to detail and her down to earth and playful disposition. She has 4 children and is married to Dr. Tamir Keshen, a Pediatric Surgeon.

Participating Faculty Members
Payam Abrishami, MD
Abrishami Dermatopathology
Agoura Hills, CA

Ryan “Dutch” Berry, MD
Western Pathology Inc.
Santa Barbara, CA

 Ryanne Brown, MD, MBA

Innovative Diagnostics
San Luis Obispo, CA
Dr. Brown completed her residency training in Anatomic and Clinical Pathology followed by Surgical Pathology and Dermatopathology fellowships at Stanford. She is board certified in Anatomic Pathology, Clinical Pathology, and Dermatopathology and currently serves as a Clinical Assistant Professor in the Dermatopathology division at Stanford with a co-appointment at the VA Palo Alto Medical center. She splits her time between the bay area and the central coast, where she signs out dermatopathology for Innovative Diagnostics. Her interests include cutaneous lymphoma, histiocytic neoplasms, and soft tissue neoplasms.

 Aegean Chan, MD
Dermatopathologist, Mission Pathology Consultants
Medical Director, California Dermatology Group
Santa Barbara, CA
Dr. Chan is a fellowship-trained and board-certified dermatopathologist, practicing with Mission Pathology Consultants, as well as a practicing dermatologist and the medical director of California Dermatology Group. She trained in Dermatology at the Montefiore Medical Center - Albert Einstein College of Medicine to, where she served as the Chief Resident during her final year. Dr. Chan then completed a fellowship in Dermatopathology at Montefiore Medical Center- Albert Einstein College of Medicine and Dermpath Diagnostics in New York.
She is an adjunct professor of dermatopathology at Keck School of Medicine at the University of Southern California and she is the recipient of a teaching award for her work teaching dermatopathology to residents in the USC dermatology department. Her most recent work on regressed melanoma is included in the fourth edition of the World Health Organization Classification of Skin Tumours.

 Julian Davis, MD, MA

Assistant Clinical Professor
Dept Hematology/Oncology
UCLA Health, Santa Barbara CA
Dr. Julian Davis is a hematologist and medical oncologist who practices in Santa Barbara. He sees patients with all types of cancer, with a specialized interest in hematologic malignancies, melanoma and clinical trials. He is board certified in hematology, medical oncology and internal medicine.
Dr. Davis completed his fellowship training in hematology and oncology at the University of California Davis Comprehensive Cancer Center, where he served as co-chief fellow in his third year. He completed his internal medicine residency at the University of Pennsylvania Health System, and received his medical degree from the Royal College of Surgeons in Dublin, Ireland. He earned his Bachelor of Science degree in Cell and Developmental Biology and his Master of Arts degree in Molecular, Cellular, and Developmental Biology from the University of California, Santa Barbara.
Prior to joining UCLA Health, Dr. Davis worked as a hematologist-oncologist at Santa Barbara's Ridley-Tree Cancer Center, where he served as the site principal investigator for several US Oncology Research (USOR) and Translational Research in Oncology (TRIO) clinical trials. He was an American Cancer Society distinguished medical honoree in 2020 and 2023, and also received an Excellence in Teaching Award from the Santa Barbara Cottage Hospital Internal Medicine Residency Program in 2020. Dr. Davis was raised in Santa Barbara, and is incredibly grateful to be able to practice cutting edge care in his hometown.

Lawrence Eichenfield, MD
Professor of Clinical Dermatology
UC San Diego
La Jolla, CA

 David Fiorentino, MD, PhD
Professor of Dermatology and Associate Residency Program Director
Stanford School of Medicine
Redwood City, CA
Department of Dermatology
Department of Medicine, Division of Rheumatology
David Fiorentino is a Professor in the Department of Dermatology at Stanford School of Medicine where he has been on faculty since 2002.  He has co-directed a multidisciplinary dermatology-rheumatology clinic there since 2004.  He specializes in the treatment of patients with rheumatic skin disorders, with a focus on dermatomyositis and systemic sclerosis, but also sees patients with many other medical dermatological disorders.  His research interests are mostly within dermatomyositis, and he is particularly focused on identifying novel autoantigens and their clinical associations as well as their role in disease pathogenesis.  He also conducts clinical trials for patients with dermatomyositis and scleroderma.  He is a founding member and past president of the Rheumatologic Dermatology Society, and has served on numerous scientific advisory boards, including the Myositis Association, Lupus Foundation, and National Psoriasis Foundation.
Dr. Fiorentino is a native Californian and attended Stanford Medical School before doing his internship at University of Colorado and then completing his dermatology residency at Stanford, where he served as Chief Resident.  He previously served as Associate Residency Program Director at Stanford from 2010-2-23.  He currently lives in Menlo Park, CA, and enjoys calisthenics, hiking, and golfing.

Kenneth Gordon, MD
Chair, Professor
Department Dermatology
Medical College of Wisconsin
Milwaukee, WI

Ursula Lang, MD
Associated Medical Pathology Group
Los Gatos, CA

Kavita Mariwalla, MD
Founder, Mariwall Dermatology
President-elect ASDS
West Islip, NY
Dr. Kavita Mariwalla is a board certified dermatologist and nationally recognized key opinion leader in dermatology and dermatologic surgery.  Her expertise is in the areas of anti-aging procedures and skin cancer treatment. She is sought after for opinions on cosmetic formulations and is regularly invited as a featured speaker in the United States and overseas.
Prior to starting her own private practice, Dr. Mariwalla was the Director of Cutaneous Oncology at St. Luke’s – Roosevelt and Beth Israel Medical Centers in New York. Dr. Mariwalla has been recognized for extensive work in the area of dermatologic education and is considered an expert injector of fillers and neuromodulators. She has written two editions of the widely used book, Primer in Dermatologic Surgery, which is highly regarded by residents and seasoned dermatologic surgeons.  She is also the author of the Cosmeceutical Compendium, an encyclopedic guide on ingredients commonly used in cosmetic formulations.  Most recently, Dr. Mariwalla released her fourth book entitled The Business of Dermatology. She is also the host of the popular Instagram Live series 21@21.
In addition to authoring several books, Dr. Mariwalla is editor of “Surgical Pearls” for the Journal of the American Academy of Dermatology and is Vice President of the American Society for Dermatologic Surgery. She has served on the Board of Directors of the Women’s Dermatologic Society and American Society for Dermatologic Surgery in the past and is a three-time recipient of the ASDS President’s Award for outstanding contributions to the field of dermatologic surgery. Dr. Mariwalla received the prestigious honor of “Iron Surgeon” at the 2019 ASDS meeting.
On the national and international stage, Dr. Mariwalla is noted for sharing her injection techniques during live demonstrations at the American Academy of Dermatology annual meetings and is prolific in her writing and speaking engagements at home and abroad. Her private practice has been nominated for the “Best of Long Island,” since its inception in 2012. She has also been recognized as a “Super Doctor” and “Top Doctor” by Castle Connolly for the last four years. Dr. Mariwalla earned her degree in medicine at the Yale School of Medicine where she also completed her dermatology residency and fellowship training.
When not working, you can find Dr. Mariwalla building LEGO® with her three boys and trying to perfect pizza on the BBQ alongside her husband Kabir.

 Alexander Miller, MD
Clinical Professor of Dermatology
UC Irvine
Skin Cancer and Reconstructive Surgery Center
Yorba Linda, CA

Johanna Moore, MD
Co-Medical Director
Innovative Diagnostics
San Luis Obispo, CA

 Melanie Palm, MD, MBA, FAAD, FAACS
Medical Director, Art of Skin MD
Solana Beach, CA
Melanie Palm, MD, MBA, FAAD, FAACS is a board-certified dermatologist and cosmetic surgeon, Associate Volunteer Clinical Professor at University of San Diego, California, and Founding Medical Director of Art of Skin MD in Solana Beach, CA.  In 2022, she was recognized by Newsweek as a Top 25 U.S. Cosmetic Dermatologist.  She completed her medical training in Chicago, first at the University of Chicago where she received her MD/MBA and then at Rush University Medical Center, completing her dermatology residency and serving as Chief Resident during her final year.
Dr. Palm’s clinical practice is blended, spanning general dermatology to advanced cosmetic procedures including liposuction, lasers and energy devices, injectables, and vein surgery.  She has lectured over 500 times on five continents on topics including cosmetic surgery, cutaneous malignancies, patient safety, and practice management.  Dr. Palm has published over 50 medical articles in peer-reviewed journals and six book chapters on a variety of dermatologic topics. She is a clinical investigator for over 45 studies in the field of dermatology Dr. Palm serves on Advisory Boards for all major injectable devices and multiple skin care, sunscreen, and light and energy device companies.
She is the recipient of the 2014 ASDS Outstanding Service Award and serves on multiple committees and boards for dermatology and cosmetic surgery societies. Dr. Palm also contributes as a media expert to numerous national media TV and print publications including, Vogue, Huffington Post, The Today Show, The Doctors, Instyle, Elle, and Allure.

 Jennifer Soung, MD
Director of Clinical Research, Southern California Dermatology
Santa Ana, CA
Clinical Professor, Harbor University of California
Los Angeles, CA
Director of Clinical Research, Southern California Dermatology, Santa Ana, CA, Clinical Professor at Harbor University of California, Los Angeles

Dr. Jennifer Soung is a board certified dermatologist and the director of clinical research at Southern California Dermatology in Santa Ana, CA. Dr. Soung is an expert in medical dermatology and clinical research focusing on chronic autoimmune skin diseases. She is on Clinical Faculty at Harbor University of California, Los Angeles and on the medical board of the National Psoriasis Foundation.

Learning Objectives
As a result of participating in this activity, the participants will be able to:
1. Discuss new approaches to therapy including pathway targeted therapy in the treatment of melanoma.
2. Assess the role of diagnostic tools and technology in diagnosis and detection of skin cancers.
3. Compare and contrast the efficacy and safety of agents, devices, and techniques currently available in aesthetic and procedural dermatology.
4. Integrate into daily practice evidence-based recommendations on new and emerging therapies for common dermatologic diseases.
5. Analyze treatment approaches for the pediatric patient with common as well as complex skin diseases.
6. Implement updated strategies for managing acne, rosacea, atopic dermatitis, contact dermatitis and psoriasis.
7. Recognize the factors that are important in selecting appropriate filler agents for treating different areas of the face and targeted planar depths.
8. Determine the appropriate nonsurgical techniques for facial rejuvenation based on an enhanced understanding of facial anatomy.
9. Explain the roles of currently available biologic agents in the treatment of psoriasis and psoriatic arthritis, and appropriately incorporate newer biologics into therapeutic practice as these become available.
10. Incorporate the recent research advances in understanding and treating pediatric dermatology issues such as atopic dermatitis and pediatric acne.

Continuing Education Credit
Joint Provider Accreditation Statement

 This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and the Foundation for Dermatology Education. The University of Louisville is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit
 The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note:
California PAs, California RNs and California NPs can all earn AMA PRA Category 1 Credit(s)™.

Special Services

All individuals are encouraged to participate. To request disability arrangements, please contact at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.


CLICK HERE for a copy of the course brochure (Available Soon)

Registration Options and Fees:
1. Residents/Fellows  $150
2. All Others - $595
3. Industry Representative  $2,000

Registration for this event is now closed. You may still attend the conference by registering as a walk-in with Gregory Cameron at the welcome desk.

Refund Policy
Requests for cancellation must be submitted to on or before Friday, April 19, 2024. Requests received on or before Friday, April 19, 2024 will receive a full refund less a $50 processing fee. No refund will be given for requests received after Friday, April 19, 2024.


Details for Lodging/Reservations will be forwarded upon completion of registration.

General Venue Information (Not For Reservations)
CLICK HERE to go to the Ojai Valley Inn Website

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.

We thank our supporting and exhibiting companies for their participation in the conference! A final listing of supporters and exhibitors will be available at the meeting.